Garry Arthur Neil - CEO and Chairman of the Board, Director at Avalo Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO and Chairman of the Board, Director
Stock Symbol
AVTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Garry Arthur Neil since 12/28/2023

Holdings reported by Garry Arthur Neil for Avalo Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 195K $101K $0.52 Aug 13, 2024 Direct Common Stock
Common Stock 60 $31.20 $0.52 Aug 13, 2024 Direct
Stock Option (Right to Buy) 500K Aug 13, 2024 Direct Common Stock

Transactions reported by Garry Arthur Neil for Avalo Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.